HP and fatty liver disease: Notably, moderate-to-severe hepatic steatosis (SteatoTest ≥ S2) was more frequent among patients with elevated zonulin (78.6%) compared to those with lower levels (55.3%), reflecting a potential trend (p = 0.10).